Kintor Pharmaceutical Ltd Ordinary Shares (SEHK:9939)

APAC company
add to virtual portfolio
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - 9939

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - 9939

  • Market CapHKD0.000m
  • SymbolSEHK:9939
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINKYG5273B1077

Company Profile

Kintor Pharmaceutical Ltd is a clinical-stage novel drug developer in China focused on the proprietary R&D of drugs for cancers and other AR-related diseases. The company's drug candidate, Proxalutamide, is a drug undergoing phase III clinical trials in China and phase II clinical trials in the United States for mCRPC as well as clinical trials for breast cancer. Its pipeline of five drug candidates includes Proxalutamide (GT0918); Pyrilutamide (KX-826); ALK-1 (GT90001); Detorsertib (GT0486); and Hedgehog/SMO Inhibitor (GT1708F). It operates in a single segment focusing on research and development of innovative medicine products.

Latest 9939 news

Currently there for this company. Visit our news hub for other news .